---
title: "Novartis Pharma GmbH — Ownership Dossier"
canonical: https://whiteintel.dev/entity/94c80db4-ba0d-56b8-8eb1-e841e7e2be61
json: https://whiteintel.dev/api/public/dossier/94c80db4-ba0d-56b8-8eb1-e841e7e2be61
identifier: lei:529900OVNGQLN18QMN97
jurisdiction: AT
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Novartis Pharma GmbH

**Type:** Company  
**Jurisdiction:** AT  
**Identifier:** `lei:529900OVNGQLN18QMN97`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/94c80db4-ba0d-56b8-8eb1-e841e7e2be61  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/94c80db4-ba0d-56b8-8eb1-e841e7e2be61  

## Registry profile

- **Status:** LAPSED  
- **Legal form:** `AXSB`  
- **Source:** GLEIF  

## Ownership & control

### UBO chain (walk to the ultimate owner)

A **2-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Provenance

- GLEIF — https://search.gleif.org/#/record/529900OVNGQLN18QMN97

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Novartis Pharma GmbH**. Human view: https://whiteintel.dev/entity/94c80db4-ba0d-56b8-8eb1-e841e7e2be61 · Structured JSON: https://whiteintel.dev/api/public/dossier/94c80db4-ba0d-56b8-8eb1-e841e7e2be61._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._